UNSPSC 51112026: Acalabrutinib

Medication used to treat a type of non-Hodgkin lymphoma known as mantle cell lymphoma. Specifically, it is for people who had previously been treated with another therapy.

UNSPSC 51112026 Acalabrutinib is a Commodity code. The recent state and local opportunities tagged with this code show minimal alignment with the pharmaceutical product itself. Of the sixteen recent state and local notices in the source block, only two represent actual pharmaceutical procurements—Seminole County's purchase of naloxone and drug deactivation systems (IFB60459723LAS, response due July 26, 2026) and Tucson Fire Department's solicitation for BLS/ALS pharmaceuticals and supplies plus vending systems (RFP 260217, response due June 24, 2026)—while the remainder are vendor networking events, educational forums, surveys, or unrelated notices. The code shows no recent activity directly soliciting acalabrutinib or other oncology pharmaceuticals from state and local buyers.

State and local procurement under pharmaceutical-related codes spans health department purchases, emergency medical services supply, forensic laboratory reagents, and county/municipal healthcare clinic operations. Issuing bodies include county health departments (Seminole County, Pinellas County), municipal fire departments (Tucson, Little Rock), and county benefits administration (Collier County). Geographic spread across recent notices includes Texas, Florida, and Arizona, with significant networking and vendor outreach activity in Florida and Texas. The preponderance of recent notices—Marion County Reverse Trade Show, Williamson County Vendor Forum, Indian River County Open House, Collin County Purchasers Forum, Pasco County How to Do Business Event, FAPPO Annual Tradeshow, and Central Florida Chapter NIGP Reverse Trade Show—reflects state and local agencies building vendor pipelines rather than executing formal procurements for specific pharmaceutical lines. The code itself appears to carry minimal current procurement signal; businesses evaluating this UNSPSC should verify that state and local healthcare purchasing systems actually tag acalabrutinib acquisitions under 51112026 and cross-reference recent RFP activity at target customer health systems and pharmacy benefit programs before committing development resources.